Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LUTEINIZING HORMONE (LH) - ANVISA Registration 80002670093

Access comprehensive regulatory information for LUTEINIZING HORMONE (LH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80002670093 and manufactured by INNOVITA (TANGSHAN) BIOLOGICAL TECHNOLOGY CO., LTD. The registration is held by RENYLAB QUÍMICA E FARMACÊUTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80002670093
Registration Details
ANVISA Registration Number: 80002670093
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

TESTE DE OVULAÇÃO FAMIVITA
Risk Class II

Registration Details

80002670093

25351429115201601

00562583000144

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

May 02, 2017

VIGENTE

09/18/2025 19:00:01